Comprehensive Obesity Care, Not Just GLP-1s
ACHP member plans are leading the way with evidence-based prescribing, lifestyle integration and smart coverage that ensures the right patients get the right treatment at the right time.
ACHP member plans are leading the way with evidence-based prescribing, lifestyle integration and smart coverage that ensures the right patients get the right treatment at the right time.
ACHP released a statement on the Trump Administration’s goal to lower the cost of prescription drugs.
ACHP submitted comments to HHS/Department of the Treasury/Department of Labor on the tri-agency’s request for information on the Prescription Drug Machine-Readable File Requirement in the Transparency in Coverage Final Rule.
ACHP strongly supports the inclusion of Medicare Part B drugs and the renegotiation of previously selected drugs from 2026 and 2027.
ACHP calls on policymakers to restore accountability to the FDA’s Accelerated Approval Pathway so effective therapies can reach patients facing serious, life-threatening diseases.
